KIT and mesenchymal cell neoplasm: This therefore raises the question as to whether the diagnosis of all previously undefined mesenchymal tumours of the GI tract where c-kit immunostaining was not performed should be revised and patients with confirmed GISTs contacted with a view to further follow up.